Macular degeneration (age-related) - pegaptanib and ranibizumab: Expert comments on the ACD Expert comments on the ACD: Mr Simon Harding Expert comments on the ACD: Mrs Jennifer Nosek Expert comments on the ACD: Professor Andrew Lotery This page was last updated: 30 March 2010